Amgen Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
Amgen (AMGN) Tops Q2 EPS by 32c, Reaffirms FY Guidance
August 3, 2021 4:03 PM EDTAmgen (NASDAQ: AMGN) reported Q2 EPS of $4.38, $0.32 better than the analyst estimate of $4.06. Revenue for the quarter came in at $6.5 billion versus the consensus estimate of $6.43 billion.
GUIDANCE:
Amgen sees 2021 EPS of $16.00-$17.00, versus the consensus of $16.34. Amgen sees 2021 revenue of... More



